Signs positive for biotech deal activity in 2010
This article was originally published in Scrip
If the activity seen in late December is anything to go by, 2010 could be a bumper year for deal-making, particularly in biotech. December was a busy month, with a raft of new, mostly biotech-related deals involving big pharma. Companies including Teva, AstraZeneca Pfizer, Lilly and GSK announced deals worth over $2 billion in total.